Chronic myeloid leukaemia trials in Russia
6 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 4Taking peopleAsciminib Roll-over Study
- Where
- Moscow, Saint Petersburg
- Age
- 7 years to 100 years
- People
- 347 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00 - Phase 3Taking peopleStudy of Olverembatinib (HQP1351) in Patients With CML-CP
- Where
- Moscow, Saint Petersburg
- Age
- 18 years and over
- People
- 333 worldwide
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT06423911 · EU 2024-511495-32-00 - Phase 3Taking peopleA Phase 3 Study for the Efficacy and Safety of Radotinib in CP-CML Patients With Failure or Intolerance to Previous TKIs
- Where
- Barnaul, Kirov, Moscow, Saint Petersburg
- Age
- 18 years and over
- People
- 173 worldwide
- Run by
- Il-Yang Pharm. Co., Ltd.
See details and how to joinNCT03459534 - Phase 2Taking peopleOptimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Malignancies and a Partially Mismatched Donor
- Where
- Saint Petersburg
- Age
- 18 years to 70 years
- People
- 60
- Run by
- St. Petersburg State Pavlov Medical University
See details and how to joinNCT07238712 - Phase 2Taking peopleSorafenib Relapase Prophylaxis After HCT With PTBCy Regimen
- Where
- Saint Petersburg
- Age
- 18 years to 75 years
- People
- 88
- Run by
- St. Petersburg State Pavlov Medical University
See details and how to joinNCT06532084 - Phase 2Taking peopleVitamin A and D Supplementation in Allogeneic HCT
- Where
- Saint Petersburg
- Age
- 18 years and over
- People
- 220
- Run by
- St. Petersburg State Pavlov Medical University
See details and how to joinNCT06508099